Yamamoto Kenjiro, Itoi Takao, Sofuni Atsushi, Tsuchiya Takayoshi, Tsuji Shujiro, Tanaka Reina, Tonozuka Ryosuke, Honjo Mitsuyoshi, Mukai Shuntaro, Kamada Kentaro, Fujita Mitsuru, Asai Yasutsugu, Matsunami Yukitoshi, Nagakawa Yuichi
Department of Gastroenterology and Hepatology, Tokyo Medical University, Japan.
Department of Third, Tokyo Medical University, Japan.
Intern Med. 2018 Jun 1;57(11):1523-1531. doi: 10.2169/internalmedicine.9779-17. Epub 2018 Feb 9.
Objective Autoimmune pancreatitis (AIP) has been recognized as a benign disease, which that shows a prompt response to corticosteroid treatment (CST). It was previously believed to not be associated with cyst formation; however, a few cases of AIP-associated pancreatic cyst (PC) have been reported. Some cases were reported to have been effectively treated by CST, while others were refractory to CST. Many of the patients received interventional treatment. Until now, there has been no consensus on the therapeutic strategies for AIP-associated PC. The aim of the present study is to describe a therapeutic strategy for this condition. Methods We conducted a retrospective study of 5 cases of AIP-associated PC that were treated by endoscopic ultrasonography-guided pancreatic fluid collection drainage (ESPD) or CST at Tokyo Medical University Hospital between March 2012 and October 2016, analyzed the therapeutic outcomes, and performed a literature review. Results The initial treatments included CST (n=2) and ESPD (n=3). All of the PCs disappeared after treatment In 1 of the patients who received CST case and 3 of the patients who received ESPD; however, the PC did not disappear in one of the patients who received CST (corticosteroid maintenance therapy), even after the dose of corticosteroids was increased; ESPD was eventually performed and the PC disappeared. There were no procedure-related complaints. Conclusion We propose that CST be administered as the first-line treatment for AIP-associated PC, particularly in cases of PC without a history of CST. However, ESPD can be applied to treat cases of corticosteroid refractory PC.
目的 自身免疫性胰腺炎(AIP)已被公认为一种良性疾病,对皮质类固醇治疗(CST)反应迅速。以前认为它与囊肿形成无关;然而,已有几例AIP相关性胰腺囊肿(PC)的报道。一些病例据报道经CST有效治疗,而其他病例对CST难治。许多患者接受了介入治疗。迄今为止,对于AIP相关性PC的治疗策略尚无共识。本研究的目的是描述针对这种情况的治疗策略。方法 我们对2012年3月至2016年10月在东京医科大学医院接受内镜超声引导下胰液引流(ESPD)或CST治疗的5例AIP相关性PC患者进行了回顾性研究,分析治疗结果,并进行文献复习。结果 初始治疗包括CST(n = 2)和ESPD(n = 3)。所有PC在治疗后均消失,接受CST的1例患者和接受ESPD的3例患者中均如此;然而,接受CST(皮质类固醇维持治疗)的1例患者中的PC即使在增加皮质类固醇剂量后仍未消失;最终进行了ESPD,PC消失。没有与操作相关的投诉。结论 我们建议将CST作为AIP相关性PC的一线治疗方法,特别是在没有CST病史的PC病例中。然而,ESPD可用于治疗皮质类固醇难治性PC病例。